News - Spiriva


Current filters:


Popular Filters

Pfizer revenues down as patent losses hit sales

Pfizer revenues down as patent losses hit sales


Global pharma giant Pfizer has said worldwide sales fell 2% to $12.6 billion, hurt by generic competition,…

AriceptEliquisEnbrelFinancialLipitorNorth AmericaPfizerPharmaceuticalRebifSpiriva

COPD trial shows comparable efficacy in Boehringer's Spiriva Respimat and HandiHaler


One of largest chronic obstructive pulmonary disease (COPD) trials conducted to date confirms comparable…

Boehringer IngelheimEuropePharmaceuticalResearchRespiratory and PulmonarySpiriva

Boehringer Ingelheim presents positive efficacy data for tiotropium in asthma patients


German family-owned drug major Boehringer Ingelheim presented a new subset of data from the Phase III…

Boehringer IngelheimPharmaceuticalResearchRespiratory and PulmonarySpirivatiotropium

New LABA/LAMA drugs set to fracture COPD market


The drug market for chronic obstructive pulmonary disease (COPD) therapies will become more fractured…

AdvairBoehringer IngelheimGlaxoSmithKlineGlobalMarkets & MarketingPfizerPharmaceuticalRespiratory and PulmonarySpiriva

Boehringer reveals new data on olodaterol and tiotropium combo at ERS


German family-owned drug major Boehringer Ingelheim for the first time presented data from a Phase II…

Boehringer IngelheimolodaterolPharmaceuticalResearchRespiratory and PulmonarySpirivatiotropium

Boehringer's Spiriva has advantages for patients with COPD, says IQWiG


In order to widen the narrowed airways in patients with chronic obstructive pulmonary disease (COPD),…

Boehringer IngelheimEuropePharmaceuticalRegulationRespiratory and PulmonarySpiriva

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top